Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(2)

Other(1)

Detailed Status

Withdrawn1

Completed1

Terminated1

Suspended1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

withdrawn125%

completed125%

terminated125%

suspended125%

Recent Activity

0 active trials

Showing 4 of 4

terminatednot_applicable

Treating Alzheimer's and Dementia With D-ribose

NCT02260141

withdrawnphase_2

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

NCT01858480

completednot_applicable

The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind Study

NCT00821067

suspendednot_applicable

The Role of Ribose in Patients Diagnosed With Fibromyalgia

NCT00566514

Clinical Trials (4)

Showing 4 of 4 trials

NCT02260141Not Applicable

Treating Alzheimer's and Dementia With D-ribose

Terminated

NCT01858480Phase 2

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Withdrawn

NCT00821067Not Applicable

The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind Study

Completed

NCT00566514Not Applicable

The Role of Ribose in Patients Diagnosed With Fibromyalgia

Suspended

All 4 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 4